VeriMomtetrapeptide-29 argininamide은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment found for tetrapeptide-29 argininamide, and no reproductive toxicity or endocrine activity reported in available peer-reviewed literature (PubMed) or ECHA/PubChem entries; therefore no evidence of reproductive hazard. Topical peptides are generally poorly absorbed but may have low measurable systemic absorption after repeated application, so exposure is scored as low (1). Sources checked: ECHA Annex VI, SCCS/CIR lists, PubMed, ECHA dossiers, PubChem.
성분
tetrapeptide-29 argininamide
알려진 위험 없음93
/100
0
Pregnancy-safe products containing tetrapeptide-29 argininamide
Related ingredients
Frequently asked questions
- tetrapeptide-29 argininamide은 임신 중 안전한가요?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment found for tetrapeptide-29 argininamide, and no reproductive toxicity or endocrine activity reported in available peer-reviewed literature (PubMed) or ECHA/PubChem entries; therefore no evidence of reproductive hazard. Topical peptides are generally poorly absorbed but may have low measurable systemic absorption after repeated application, so exposure is scored as low (1). Sources checked: ECHA Annex VI, SCCS/CIR lists, PubMed, ECHA dossiers, PubChem.
- tetrapeptide-29 argininamide은 모유 수유 중 안전한가요?
- Same rationale as pregnancy: no reproductive or lactation-specific hazards identified in authoritative sources. Low but measurable systemic absorption from topical use is plausible, so exposure scored as low (1). Sources checked: ECHA Annex VI, CIR/SCCS, PubMed, PubChem, CosIng.
- tetrapeptide-29 argininamide은 아기 피부에 안전한가요?
- No data indicating infant-specific toxicity or harmonised classification. Because infant skin has higher permeability and the ingredient has potential for low systemic absorption in adults, exposure for 0–3 yr is increased by one category to moderate (2). No evidence to change hazard or mechanism scores. Sources checked: ECHA Annex VI, SCCS/CIR, PubMed, ECHA dossiers, CosIng, EWG.
- VeriMom은 tetrapeptide-29 argininamide을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 tetrapeptide-29 argininamide을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 tetrapeptide-29 argininamide 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.